In response to rising COVID-19 cases in our community, BJC reopened the monoclonal antibody (mAb) clinic at Christian Hospital on Tuesday, Aug. 10. The therapy (mAb) for COVID-19 has been granted emergency use authorization (EUA) by the FDA. The monoclonal antibody cocktail is administered through outpatient infusion and is indicated for high-risk outpatients who are early in their symptom presentation and not receiving oxygen related to their COVID-19 diagnosis. The BJC website provides details for ordering the treatment.